File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)

Conference Paper: Disease relapse, healthcare utilization and adverse events associated with the use of long-acting injectable antipsychotics versus oral antipsychotics in people with schizophrenia: A self-controlled case series study

TitleDisease relapse, healthcare utilization and adverse events associated with the use of long-acting injectable antipsychotics versus oral antipsychotics in people with schizophrenia: A self-controlled case series study
Authors
Issue Date1-Sep-2022
PublisherWiley
Persistent Identifierhttp://hdl.handle.net/10722/333733
ISSN
2021 Impact Factor: 2.732
2020 SCImago Journal Rankings: 1.023
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorWei, Y-
dc.contributor.authorYan, VK-
dc.contributor.authorKang, W-
dc.contributor.authorWong, I-
dc.contributor.authorCastle, DJ-
dc.contributor.authorGao, L-
dc.contributor.authorChui, CS-
dc.contributor.authorMan, K-
dc.contributor.authorHayes, JFF-
dc.contributor.authorChang, WC-
dc.contributor.authorChan, E-
dc.date.accessioned2023-10-06T08:38:38Z-
dc.date.available2023-10-06T08:38:38Z-
dc.date.issued2022-09-01-
dc.identifier.issn1053-8569-
dc.identifier.urihttp://hdl.handle.net/10722/333733-
dc.languageeng-
dc.publisherWiley-
dc.relation.ispartofPharmacoepidemiology & Drug Safety-
dc.titleDisease relapse, healthcare utilization and adverse events associated with the use of long-acting injectable antipsychotics versus oral antipsychotics in people with schizophrenia: A self-controlled case series study-
dc.typeConference_Paper-
dc.identifier.volume31-
dc.identifier.spage344-
dc.identifier.epage344-
dc.identifier.eissn1099-1557-
dc.identifier.isiWOS:000859084401293-
dc.publisher.placeHOBOKEN-
dc.identifier.issnl1053-8569-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats